Results 61 to 70 of about 3,820 (178)

AIDS Cholangiopathy Secondary to Cytomegalovirus as Possible Unmasking Immune Reconstitution Inflammatory Syndrome in Human Immunodeficiency Virus-Infected Individual: Case Report and Review of the Literature

Case Reports in Infectious Diseases, 2018
We present the first case report of cytomegalovirus (CMV) cholangiopathy as possible immune reconstitution inflammatory syndrome (IRIS) in a human immunodeficiency virus (HIV)-infected individual, within two months of starting effective HAART.
Moiz Topiwala, Nachiket Dubale, Mahender K. Medisetty, Sunil Gaikwad, Divya Patel, Sanjay Pujari   +5 more
doaj   +1 more source

The Top Five Advances in Solid Organ Transplantation in the Past Fifty Years

World Journal of Surgery, Volume 50, Issue 8, Page 2121-2124, August 2026.
Stephen J. Wigmore, Diana A. Wu
wiley   +1 more source

Cholangiocyte Organoids in Liver Transplantation; a Comprehensive Review

Transplant International
Liver transplantation is the only curative option for many liver diseases that end up in liver failure, and cholangiopathy remains a challenging complication post-liver transplant, associated with significant morbidity and potential graft loss.
C. Rejas, H. Junger
doaj   +1 more source

Obliterative cholangiopathy in acquired cystic biliary atresia type III after cyst perforation: a case report

BMC Pediatrics, 2018
Background In biliary atresia, the disease process of obliterative cholangiopathy may begin in the perinatal period; however, no chronological evidence exists on how the cholangiopathy progresses to biliary obliteration.
Tsugumichi Koshinaga, Kensuke Ohashi, Kakou Ono, Hide Kaneda, Takeshi Furuya   +4 more
doaj   +1 more source

Critical evaluation of pathogenic factors of primary biliary cirrhosis

Российский журнал гастроэнтерологии, гепатологии, колопроктологии, 2013
The aim of review. Primary biliary cirrhosis (PBC) is related to the group of autoimmune cholestasisassociated liver diseases. In the last years prevalence of PBC increased considerably, especially – in Northern European countries.
A. F. Sheptulina, M. V. Mayevskaya, V. T. Ivashkin   +2 more
doaj  

Viral infections of the biliary tract

The Saudi Journal of Gastroenterology, 2008
Bacterial infections of the biliary tract are often considered to be an important cause of acute cholangitis. Viral infections of the biliary tract however, are very often mistaken as viral hepatitis.
Gupta Ekta, Chakravarti Anita
doaj  

Lipoprotein X in the Setting of COVID-19–Induced Cholangiopathy: An Unforeseen Event

Annals of Internal Medicine: Clinical Cases
Elevated low-density lipoprotein cholesterol (LDL-C) is a well-known culprit for atherosclerosis; however, elevated lipoprotein X (LpX), an abnormal lipoprotein as dense as LDL-C, may confound differentiation between true hyperlipidemia and cholestasis ...
Hardik Patel, Felix Berglund, Christina C. Lindenmeyer, Nicholas Ruthmann   +3 more
doaj   +1 more source

COVID-19 Induced Cholangiopathy: A Case Report

Case Reports in Gastroenterology
Introduction: COVID-19, although primarily a respiratory illness, has been linked to complications in multiple organ systems, including the liver.
Bassem Al Hariri, Muhammad Sharif, Lujain Al-Emadi, Richard Shamoon, Memon Noor Illahi, Nabil S. Mahmood, Muayad Kasim Khalid   +6 more
doaj   +1 more source

Syphilitic Cholangiopathy Mimicking Primary Sclerosing Cholangitis

Infectious Disease Reports
Introduction: Syphilis is a sexually transmitted disease with variable symptoms, often imitating various other disorders. Syphilis progresses through primary, secondary, latent, and tertiary stages, each with distinct clinical manifestations.
Adriana Gregušová, Michal Gergel, Miroslav Žigrai   +2 more
doaj   +1 more source

Autoimmune cholangiopathy presenting as a mimicker of hilar cholangiocarcinoma

VideoGIE
Background and Aims: Autoimmune cholangiopathy can mimic cholangiocarcinoma. This video highlights the presentation and management of a patient with obstructive jaundice in the setting of a biliary stricture concerning for hilar cholangiocarcinoma who ...
Nicholas Hebda, MD, Ikechukwu Achebe, MD, Prashanth Rau, MD, Navine Nasser-Ghodsi, MD, Neil B. Marya, MD   +4 more
doaj   +1 more source